UH Dubrava
Zagreb, 10000, Croatia
NCT Number: NCT07522424
This study evaluates whether re-sterilized (reprocessed) ablation catheters are as effective and safe as new ablation catheters when used for electrophysiological procedures. Adult patients scheduled for catheter ablation will be randomly assigned to undergo the procedure using either a new catheter or a re-sterilized catheter, with identical procedural techniques applied in both groups. The study will compare procedural efficiency, safety, costs, and environmental impact between the two approaches. The results may support more sustainable and cost-effective use of medical devices in cardiac electrophysiology.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Zagreb, 10000, Croatia
This is a prospective, randomized, controlled non-inferiority trial comparing re-sterilized (reprocessed) and new ablation catheters in electrophysiological procedures. The study will be conducted at University Hospital Dubrava, a high-volume tertiary center for cardiac electrophysiology.
Patients scheduled for electrophysiological procedures will be randomized in a 1:1 ratio using a computer-generated sequence to undergo ablation with either a new or a re-sterilized catheter. All procedures will be performed by experienced electrophysiologists in accordance with standard institutional practice.
Procedure duration will be measured from groin puncture to completion of ablation. Additional procedural parameters related to ablation delivery, including duration and number of energy applications, total ablation time, and other procedural timing characteristics, will also be recorded. Fluoroscopy time and radiation dose, expressed as dose-area product (DAP), will be recorded automatically.
Catheter performance will be assessed based on achievement ablation, the number of energy applications and procedural assessment of catheter integrity, flexibility, and electrical properties.
Procedural safety will be evaluated by monitoring peri-procedural and post-procedural adverse events, including pericardial effusion, stroke, vascular complications, and death. Laboratory markers of inflammation, infection, and hemolysis will be obtained at predefined time points before and after the procedure. Blood cultures will be collected before and after the procedure to assess potential infectious complications.
Patients will be followed clinically during hospitalization and after discharge through telephone contact and routine outpatient visits.
Economic evaluation will include direct procedural costs, catheter costs, and re-sterilization costs. Environmental impact will be assessed based on medical waste generation and estimated carbon footprint associated with catheter use.
Re-sterilization of ablation catheters will be performed according to the validated internal protocol of University Hospital Dubrava, which has been used in routine clinical practice.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will undergo electrophysiological procedure (ablation). The intervention consists of the use a new ablation catheter.
The key distinguishing feature of this intervention is the comparison of reprocessed versus new single-use catheters, while all other procedural aspects, including operator technique, energy delivery protocol, and peri-procedural care, are standardized and identical between groups.
Participants will undergo electrophysiological procedure (ablation). The intervention consists of the use of a reprocessed ablation catheter. The reprocessed catheter has undergone validated cleaning, resterilization, and functional testing in accordance with regulatory and safety standards prior to reuse. The key distinguishing feature of this intervention is the comparison of reprocessed versus new single-use catheters, while all other procedural aspects, including operator technique, energy delivery protocol, and peri-procedural care, are standardized and identical between groups.
Time frame: From the start of the index ablation procedure until its completion.
Procedure duration, expressed in minutes, measured from groin puncture to completion of ablation.
Time frame: From the start of the index ablation procedure until its completion
Successful completion of ablation defined as achievement of electrical isolation of the target tissue
Time frame: Periprocedural
Amount of medical waste generated per ablation procedure, expressed in kilograms.
Time frame: From the start of the index ablation procedure until its completion
Total fluoroscopy time, expressed in minutes, recorded during the ablation procedure.
Time frame: From the start of the index ablation procedure until its completion
Radiation exposure expressed as dose-area product (DAP), automatically recorded during the ablation procedure.
Time frame: Up to 30 days following the index ablation procedure
Number of participants with peri-procedural and post-procedural complications, including pericardial effusion, stroke, vascular complications, and death.
Time frame: Periprocedural
Direct procedural costs per patient, including catheter cost, procedure-related costs, and re-sterilization costs, expressed in local currency.
Time frame: From the start of the index ablation procedure until its completion.
Estimated carbon footprint associated with the ablation procedure and catheter use, expressed in CO₂-equivalent units.
Contact information is provided by the study sponsor or research team.
Ivan Zeljković, PhD,MD
CONTACT
Mihovil Santini, MD
CONTACT
Ivan Zeljkovic
Other
Acronym: RE-USE EP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02636712
Arhythmia, Arrhythmias, Cardiac
Nanjing, Jiangsu, China
View Trial Details